Literature DB >> 15722637

Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.

Stefan Florian1, Maria-Theresa Krauth, Ingrid Simonitsch-Klupp, Wolfgang R Sperr, Robert Fritsche-Polanz, Karoline Sonneck, Manuela Födinger, Hermine Agis, Alexandra Böhm, Friedrich Wimazal, Hans-Peter Horny, Peter Valent.   

Abstract

BACKGROUND: In contrast to aggressive mastocytosis, patients with indolent systemic mastocytosis (ISM) usually present with urticaria pigmentosa-like skin lesions. In those who lack skin lesions, mastocytosis is often overlooked or confused with endocrinologic, allergic, or other internal disorders. CASE REPORT AND
RESULTS: We report on a 33-year-old male patient in whom severe hypotensive episodes occurred after contact with ants or yellow jackets. Since no specific IgE was detected, the serum tryptase concentration was measured and found to be clearly elevated (70 ng/ml). Consecutive staging and examination of the bone marrow revealed ISM. The patient was advised to circumvent insect contact, to take antihistamines on demand, and to carry an epinephrine self-injector for emergency events. In a retrospective analysis of 40 patients seen between 1988 and 2003, only 2 had a life-threatening mediator-related episode before ISM was diagnosed.
CONCLUSIONS: Our report confirms the diagnostic value of tryptase in patients with suspected mastocytosis. In addition, the report suggests that the lack of typical skin lesions does not exclude an indolent form of mastocytosis even if the serum tryptase is clearly elevated. Finally, our case further shows that mastocytosis can be an important differential diagnosis to be considered in patients with unexplained anaphylactoid or other mediator-related symptoms. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15722637     DOI: 10.1159/000083954

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  15 in total

Review 1.  Tryptase genetics and anaphylaxis.

Authors:  George H Caughey
Journal:  J Allergy Clin Immunol       Date:  2006-04-27       Impact factor: 10.793

2.  Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis.

Authors:  Cem Akin; Linda M Scott; Can N Kocabas; Nataliya Kushnir-Sukhov; Erica Brittain; Pierre Noel; Dean D Metcalfe
Journal:  Blood       Date:  2007-07-16       Impact factor: 22.113

Review 3.  Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Authors:  A Matito; I Alvarez-Twose; J M Morgado; L Sánchez-Muñoz; A Orfao; L Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2014-08       Impact factor: 4.806

Review 4.  Hymenoptera Anaphylaxis and C-kit Mutations: An Unexpected Association.

Authors:  Patrizia Bonadonna; Massimiliano Bonifacio; Carla Lombardo; Roberta Zanotti
Journal:  Curr Allergy Asthma Rep       Date:  2015-08       Impact factor: 4.806

Review 5.  Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?

Authors:  A Matito; M Carter
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

6.  Mastocytosis: a paradigmatic example of a rare disease with complex biology and pathology.

Authors:  Peter Valent
Journal:  Am J Cancer Res       Date:  2013-04-03       Impact factor: 6.166

Review 7.  Anesthetic considerations in pediatric mastocytosis: a review.

Authors:  Norma J Klein; Shad Misseldine
Journal:  J Anesth       Date:  2013-02-14       Impact factor: 2.078

Review 8.  Pharmacological targeting of the KIT growth factor receptor: a therapeutic consideration for mast cell disorders.

Authors:  B M Jensen; C Akin; A M Gilfillan
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

Review 9.  Mastocytosis.

Authors:  Melody C Carter; Dean D Metcalfe; Hirsh D Komarow
Journal:  Immunol Allergy Clin North Am       Date:  2013-10-07       Impact factor: 3.479

Review 10.  The problem of anaphylaxis and mastocytosis.

Authors:  Ulrich R Müller; Gabrielle Haeberli
Journal:  Curr Allergy Asthma Rep       Date:  2009-01       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.